PT  - JOURNAL ARTICLE
AU  - Thompson, Hallie
AU  - Nichols, Laura
AU  - Gonzalez Santiago, Tania
TI  - Bullous fixed drug eruption following administration of the recombinant adjuvant Shingrix vaccine
AID  - 10.1136/bcr-2020-241293
DP  - 2021 Aug 01
TA  - BMJ Case Reports
PG  - e241293
VI  - 14
IP  - 8
4099  - http://casereports.bmj.com/content/14/8/e241293.short
4100  - http://casereports.bmj.com/content/14/8/e241293.full
SO  - BMJ Case Reports2021 Aug 01; 14
AB  - A 51-year-old woman with Crohn’s disease presented with a bullous rash on her left arm and axilla 2 days after receiving her second dose of the recombinant adjuvant Shingrix vaccine. PCR for herpes simplex virus (HSV) 1, HSV 2 and varicella zoster virus was negative. Punch biopsy revealed changes that were consistent with a bullous fixed drug eruption. She was successfully treated oral prednisone and topical triamcinolone cream. This is the first known case of a bullous fixed drug eruption due to the recombinant adjuvant Shingrix vaccine.